Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant...

Area of Science:

• Infectious Diseases
• Pharmacology
• Microbiology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen causing serious infections, including endocarditis.
• Endocarditis is an infection of the heart lining or valves, often requiring effective antimicrobial therapy.
• Developing novel treatment strategies for MRSA infections is crucial due to rising antibiotic resistance.

Purpose of the Study:

• To evaluate the efficacy of fosfomycin in combination with vancomycin or gentamicin against experimental MRSA endocarditis.
• To determine if these combination therapies can eradicate MRSA from infected heart vegetations.

Main Methods:

• An experimental endocarditis model was established in rabbits using MRSA.
• Rabbits were treated with either fosfomycin plus vancomycin or fosfomycin plus gentamicin for five days.
• Vegetations were cultured post-therapy to assess bacterial eradication.

Main Results:

• Both combination therapies, fosfomycin-vancomycin and fosfomycin-gentamicin, demonstrated high efficacy.
• All rabbits treated with either combination therapy achieved sterile vegetations, indicating complete bacterial eradication.
• No adverse effects were reported in the abstract, suggesting good tolerability.

Conclusions:

• Fosfomycin in combination with either vancomycin or gentamicin is a highly effective treatment for experimental MRSA endocarditis.
• These findings support the potential clinical utility of these antibiotic combinations for treating severe MRSA infections.
• Further clinical studies are warranted to confirm the efficacy and safety of these regimens in human patients.